FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence - FDA Press Releases

FDA approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.

from FDA Press Releases RSS Feed https://ift.tt/2vRWQZi
via IFTTT